Literature DB >> 6185791

Differences between the effects of calcium antagonists in the pithed rat preparation.

M Spedding.   

Abstract

The drugs classed as calcium antagonists display marked differences in vitro and it has been proposed that different subclasses of antagonists exist (Spedding M. Naunyn Schmiedebergs Arch Pharmacol 1982; 318:234-40). The effects of these drugs have now been compared in vivo using the pithed rat preparation. Whereas the hypotensive effects of verapamil (0.1-3 mumol/kg i.v.) and diltiazem (0.1-10 mumol/kg i.v.) were accompanied by prolongation of PR intervals and second-degree atrioventricular block with little bradycardia, fendiline (0.1-30 mumol/kg i.v.), cinnarizine (0.1-10 mumol/kg i.v.), and pimozide (0.1-10 mumol/kg i.v.) reduced heart rate at hypotensive doses but had less marked effects on AV conduction, thus implying different selectivities among calcium antagonists for the sinus or AV nodes. These differences were not secondary to effects on the autonomic nervous system. In contrast, nifedipine (0.01-1 mumol/kg i.v.) had no effect on the ECG in doses which markedly reduced blood pressure elevated by an infusion of angiotensin II and thus showed specificity for vascular smooth muscle. The marked differences between the effects of the calcium antagonists in vivo confirm the disparate nature of this group of drugs. The reasons for these differences are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6185791     DOI: 10.1097/00005344-198211000-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

2.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

3.  Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

4.  Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

5.  The potencies and selectivities of four calcium antagonists as inhibitors of uterine contractions in the rat in vivo.

Authors:  M H Abel; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

6.  Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.

Authors:  M A Petty; A K Mir
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

7.  The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.

Authors:  D J Duncker; J M Hartog; P G Hugenholtz; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

8.  Differential effects of calcium channel antagonists on histamine and pentagastrin-stimulated gastric acid secretion in the rat.

Authors:  M Bouclier; M Spedding
Journal:  Agents Actions       Date:  1985-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.